spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  HIV test 

 HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Biopharmaceuticals Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 28 Nov 2018
FDA Approves Expanded Use for Ortho Clinical Diagnostics VITROS(R) HIV Combo Test
Devices Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 6 Nov 2018
FDA Approves Ortho Clinical Diagnostics VITROS(R) Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator for use on the VITROS(R) 5600 Integrated System
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 17 Jan 2018
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2017
FDA Approves Ortho Clinical Diagnostics VITROS(R) Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator on the VITROS(R) 3600 Immunodiagnostic System
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 19 Oct 2015
MedMira Receives FDA Approval for the Reveal(R) G4 Rapid HIV-1 Antibody Test
Diagnostics FDA
 HSMN NewsFeed - 18 Jul 2013
TB Biosciences, Inc. Closes $1.5 Million in Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 18 Jun 2013
Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
Diagnostics HIV/AIDS Regulatory
 HSMN NewsFeed - 4 Apr 2012
FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 21 Jun 2010
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 18 May 2010
AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
Devices Distribution
 HSMN NewsFeed - 28 Apr 2010
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra(R) (lopinavir / ritonavir) for Treatment-Experienced Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 5 Aug 2008
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 3 Jun 2008
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 7 Apr 2008
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 24 Mar 2008
BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
Biopharmaceuticals
 HSMN NewsFeed - 21 Jan 2008
AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 12 Nov 2007
Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 2 Nov 2007
Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels
Biopharmaceuticals
 HSMN NewsFeed - 17 Oct 2007
StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
Diagnostics Licensing
 HSMN NewsFeed - 10 Jul 2007
bioLytical Receives FDA Clearance to Initiate Clinical Trial for 60-Second HIV Test
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 11 Jun 2007
OraSure Technologies Receives CE Mark for OraQuick ADVANCE(R) Rapid HIV Test
Diagnostics Regulatory HIV/AIDS
 HSMN NewsFeed - 2 Apr 2007
OraSure Technologies Signs Agreement for Development of Counseling and Referral System for Home Use Rapid HIV Test Kit
Diagnostics
 HSMN NewsFeed - 5 Oct 2006
Inverness Medical Innovations, Chembio Diagnostics, Inc. and StatSure Diagnostic Systems, Inc. Announce Agreements to Market Rapid HIV and Other Tests
Diagnostics
 HSMN NewsFeed - 5 Oct 2006
Inverness Medical Innovations, Chembio Diagnostics, Inc. and StatSure Diagnostic Systems, Inc. Announce Agreements to Market Rapid HIV and Other Tests
Diagnostics
 HSMN NewsFeed - 5 Oct 2006
StatSure and Chembio Agree to End Litigation and Enter Agreement to Commercialize HIV Barrel Technology
Diagnostics
 HSMN NewsFeed - 3 Jul 2006
Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe
Biopharmaceuticals Regulatory HIV/AIDS
 HSMN NewsFeed - 30 May 2006
Chembio Receives FDA Approval for Its Rapid HIV Tests
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 8 May 2006
Pfizer to Invest $25 Million in Monogram
Diagnostics Biopharmaceuticals HIV/AIDS
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
HIV test
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!